Recombinant Varecia variegata variegata NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for guaranteed fulfillment.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is finalized during production. If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
MT-ND4L; MTND4L; NADH4L; ND4L; NADH-ubiquinone oxidoreductase chain 4L; NADH dehydrogenase subunit 4L
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-98
Protein Length
full length protein
Species
Varecia variegata variegata (Black and white ruffed lemur)
Target Names
Target Protein Sequence
MPSIFINIILAFIIALLGMLIFRSHLMSSLLCLESMMLSMFILSTLTILSLHLTMSFMMP ILLLVFAACEAAVGLALLVTVSNTYGLDYIQNLNLLQC
Uniprot No.

Target Background

Function

Function: Recombinant Varecia variegata variegata NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L) is a core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I). It catalyzes electron transfer from NADH through the respiratory chain, utilizing ubiquinone as the electron acceptor.

Protein Families
Complex I subunit 4L family
Subcellular Location
Mitochondrion inner membrane; Multi-pass membrane protein.

Q&A

What is the fundamental role of MT-ND4L in mitochondrial function?

MT-ND4L (mitochondrially encoded NADH dehydrogenase 4L) is an essential component of the mitochondrial membrane respiratory chain, specifically functioning within complex I (NADH:ubiquinone oxidoreductase). This protein enables NADH dehydrogenase activity and is directly involved in mitochondrial electron transport from NADH to ubiquinone. MT-ND4L participates in the proton-motive force-driven process of ATP synthesis, making it critical for cellular energy production .

In experimental approaches, researchers typically assess MT-ND4L function through mitochondrial isolation protocols followed by spectrophotometric assays measuring NADH oxidation rates. For accurate functional characterization, it's essential to maintain the protein within its native lipid environment or reconstitute it properly when working with recombinant forms.

How does the MT-ND4L gene structure in Varecia variegata compare to human MT-ND4L?

The MT-ND4L gene in Varecia variegata is located in the mitochondrial genome and, similar to humans, lacks introns as is characteristic of mitochondrial genes . While sharing functional conservation with human MT-ND4L, the lemur version exhibits species-specific nucleotide variations that may affect protein stability and function.

Comparative sequence analysis between lemur and human MT-ND4L reveals conserved functional domains critical for complex I assembly and activity. Research methodologies for such comparisons typically involve:

  • Multiple sequence alignment using CLUSTAL W or similar algorithms

  • Phylogenetic analysis to assess evolutionary relationships

  • Protein modeling to predict structural differences

  • Conservation scoring of amino acid positions

These comparisons are valuable for understanding how evolutionary pressures have shaped this essential mitochondrial component across primate lineages.

What genetic diversity exists in MT-ND4L across Varecia variegata subspecies?

Mitochondrial DNA diversity studies of Varecia subspecies have revealed significant genetic structure. Captive ruffed lemur populations in Madagascar, Europe, and North America show varying degrees of genetic diversity, with captive V. variegata in Madagascar demonstrating the highest haplotype diversity (Hd) and nucleotide diversity (π) values .

The genetic diversity in European Endangered Species Programme (EEP) V. variegata populations is notably lower than in Species Survival Plan (SSP) samples, with EEP having the second lowest diversity value across all studied groups . This reduced genetic diversity has important implications for conservation management of captive populations.

PopulationHaplotype Diversity (Hd)Nucleotide Diversity (π)
Captive V. variegata (Madagascar)Highest valuesHighest values
Wild V. v. editorum (south of Mangoro River)Lowest valuesLowest values
EEP V. variegataSecond lowestSecond lowest
SSP V. variegataHigher than EEPHigher than EEP

When investigating MT-ND4L specifically, researchers should employ targeted PCR amplification followed by high-resolution melt analysis or direct sequencing to identify subspecies-specific variants.

What are the optimal expression systems for producing recombinant Varecia variegata MT-ND4L?

Producing functional recombinant MT-ND4L from Varecia variegata presents several challenges due to its hydrophobic nature and membership in a multi-subunit complex. Several expression systems can be employed, each with specific advantages:

  • Bacterial expression systems: While E. coli-based systems offer high yield and ease of genetic manipulation, membrane proteins like MT-ND4L often form inclusion bodies, requiring refolding protocols that may compromise function.

  • Yeast expression systems: S. cerevisiae or P. pastoris provide a eukaryotic environment with enhanced protein folding machinery and the ability to perform post-translational modifications, improving the likelihood of obtaining functional protein.

  • Mammalian cell expression: HEK293 or CHO cells offer the most native-like environment for proper folding and assembly, though with lower yields and higher costs.

For optimal results with Varecia MT-ND4L, a yeast expression system with codon optimization and a cleavable purification tag (such as His6) provides the best balance of yield and functionality. Detergent screening (using DDM, LMNG, or digitonin) is critical during purification to maintain protein stability.

How can researchers effectively study MT-ND4L mutations identified in Varecia subspecies?

Investigating MT-ND4L mutations requires a multi-faceted approach combining computational predictions with experimental validation:

  • In silico analysis: Mutations should be evaluated using predictive algorithms (SIFT, PolyPhen-2, PROVEAN) to assess potential functional impacts. For example, similar approaches with human MT-ND4L variants have identified deleterious mutations with direct impact on protein stability and complex I function .

  • Site-directed mutagenesis: Introducing specific mutations into recombinant expression constructs allows direct testing of functional consequences.

  • Structural biology: Where possible, crystallography or cryo-EM studies of mutant proteins provide insights into structural perturbations.

  • Functional assays: Measuring enzyme kinetics, ROS production, and membrane potential in systems expressing wild-type versus mutant MT-ND4L.

When analyzing multiple mutations, it's essential to consider potential cumulative effects, as demonstrated in studies where multiple mutations in the same individual were predicted to cause a cumulative destabilizing effect on protein function .

What is the relationship between MT-ND4L variants and disease susceptibility in primates?

MT-ND4L variants have been associated with several human diseases that may have parallels in non-human primates. Most notably, whole exome sequencing studies have identified a rare MT-ND4L variant (rs28709356 C>T) with significant association to Alzheimer's disease (AD) (P = 7.3 × 10−5) . The gene-based test for MT-ND4L also showed significant association with AD (P = 6.71 × 10−5) .

For comparative research between humans and Varecia, consider:

  • Establishing cell lines from lemur tissues to assess mitochondrial function

  • Developing cybrid models incorporating lemur mitochondria in human nuclear backgrounds

  • Creating transgenic models expressing lemur MT-ND4L variants

This research has relevance beyond conservation, potentially providing insights into fundamental mechanisms of mitochondrial dysfunction in neurodegeneration across primate species.

What techniques provide the most accurate assessment of recombinant MT-ND4L incorporation into functional complex I?

Assessing proper incorporation of recombinant MT-ND4L into complex I requires specialized techniques:

  • Blue Native PAGE: This technique separates intact respiratory complexes and can verify MT-ND4L incorporation into fully assembled complex I.

  • Activity assays: NADH:ubiquinone oxidoreductase activity measurements with artificial electron acceptors like ferricyanide can assess functional integration.

  • Immunoprecipitation: Using antibodies against other complex I subunits to co-precipitate MT-ND4L confirms physical association.

  • Proteomics: Cross-linking followed by mass spectrometry can map the interaction partners of MT-ND4L within the complex.

  • Cryo-EM analysis: This can provide structural verification of proper MT-ND4L positioning within the complex.

The gold standard approach combines structural verification with functional assays to ensure both incorporation and activity of the recombinant protein.

How can genomic DNA from captive Varecia populations be effectively analyzed for MT-ND4L variants?

Analysis of MT-ND4L variants in captive Varecia populations requires careful consideration of mitochondrial DNA inheritance patterns and population structure:

  • Sampling strategy: Ensure representation across maternal lineages, as mitochondrial DNA is maternally inherited.

  • DNA extraction: For non-invasive sampling, use fecal or hair samples with specialized extraction protocols designed for degraded DNA.

  • Amplification and sequencing: Use lemur-specific primers flanking the MT-ND4L region, followed by either Sanger sequencing (for targeted analysis) or next-generation sequencing (for whole mitochondrial genome analysis).

  • Variant calling and filtering: When analyzing sequence data, apply appropriate quality filters and confirm variants through bidirectional sequencing to avoid false positives.

  • Population genetics analysis: Calculate genetic diversity metrics (haplotype diversity, nucleotide diversity) and perform FST analysis to assess population differentiation, as demonstrated in studies of captive ruffed lemurs showing significant pairwise FST values between different groups .

What are the best approaches for integrating MT-ND4L genetic data into conservation management plans?

Integrating MT-ND4L genetic data into conservation management requires:

  • Haplotype identification: Establish comprehensive databases of MT-ND4L haplotypes across wild and captive populations. Studies have identified novel haplotypes in captive populations that were not previously recorded in wild individuals .

  • Maternal lineage tracking: Due to maternal inheritance of mtDNA, track maternal lineages to maintain mitochondrial genetic diversity.

  • Breeding recommendations: Use MT-ND4L and other mtDNA data to inform breeding programs, particularly when genetic diversity is compromised, as seen in European captive V. variegata populations which showed much lower diversity than other groups .

  • Translocation planning: When considering reintroduction programs, match mitochondrial haplotypes to appropriate geographic regions based on historical distribution of haplotypes.

  • Regular monitoring: Implement periodic genetic monitoring to assess changes in MT-ND4L diversity over time, especially in small populations vulnerable to genetic drift.

How does MT-ND4L function differ between recombinant systems and native mitochondrial environments?

Recombinant MT-ND4L often exhibits functional differences compared to its native context due to several factors:

  • Lipid environment: Native mitochondrial inner membrane lipid composition differs from recombinant expression systems, affecting protein folding and function.

  • Post-translational modifications: These may be absent or altered in recombinant systems.

  • Protein-protein interactions: The complex assembly process in native systems involves precise interactions with nuclear-encoded subunits that may be suboptimal in recombinant systems.

To address these limitations, researchers can:

  • Use native lipid reconstitution methods

  • Develop co-expression systems incorporating multiple complex I subunits

  • Apply AI-driven conformational ensemble generation approaches to predict alternative functional states, as has been done for other mitochondrial proteins

  • Employ nanodiscs or liposomes with mitochondria-mimetic lipid compositions

Quantifying these differences typically involves comparative enzymatic assays, structural studies, and stability measurements between native and recombinant systems.

What novel therapeutic approaches might target MT-ND4L dysfunction in mitochondrial disorders?

While primarily a research question, understanding MT-ND4L function has potential therapeutic implications:

  • Small molecule chaperones: Compounds that stabilize mutant MT-ND4L and promote proper folding.

  • Allosteric modulators: Molecules binding to non-catalytic sites that enhance residual complex I activity.

  • Bypass therapeutics: Compounds that facilitate electron transfer around complex I defects.

  • Gene therapy approaches: Targeted delivery of wild-type MT-ND4L using mitochondrially-targeted nucleic acid systems.

Research methodologies to identify such compounds include:

  • AI-driven binding pocket identification and characterization on the protein surface to discover orthosteric and allosteric sites

  • High-throughput screening using complex I activity assays

  • Structure-based drug design utilizing the conformational ensemble of MT-ND4L

Understanding how specific mutations affect MT-ND4L structure is crucial, as studies have shown some mutations (like m.11519A>C, m.11523A>C) can be deleterious with direct impact on protein stability, while others may have minimal effect .

How does MT-ND4L genetic diversity correlate with population health in endangered Varecia variegata?

  • Diversity metrics: Captive V. variegata in Madagascar show high haplotype diversity (Hd) and nucleotide diversity (π) values, suggesting good genetic health, while wild populations of V. v. editorum south of the Mangoro River show concerning low diversity values .

  • Population structure: Significant pairwise FST values between different groups indicate strong population structure, with values ranging from 6.4% between captive V. variegata in Madagascar and wild populations of V. v. variegata, to 67.8% between EEP V. variegata and wild populations of V. v. editorum south of the Mangoro River .

Population ComparisonFST Value (%)
Captive V. variegata (Madagascar) vs. wild V. v. variegata6.4%
EEP V. variegata vs. wild V. v. editorum (south of Mangoro)67.8%

These metrics provide critical information for conservation managers about population health, inbreeding risk, and adaptive potential. Research methodologies should include comprehensive sampling across ranges, temporal sampling to track diversity changes, and integration with other genetic markers.

What techniques best preserve DNA quality for MT-ND4L analysis from field samples?

Field-based MT-ND4L research requires specialized techniques to ensure DNA quality:

  • Sample preservation: For tissue samples, use RNAlater or immediate freezing in liquid nitrogen. For non-invasive samples (feces, hair), use silica desiccation or specialized buffers that prevent degradation.

  • Extraction timing: Process samples as quickly as possible after collection, as mitochondrial DNA can degrade rapidly, especially in tropical environments where many lemur species are found.

  • PCR optimization: Use multiple displacement amplification (MDA) or other whole genome amplification techniques for samples with low DNA concentration.

  • Fragment analysis: For degraded samples, design overlapping short amplicons that collectively cover the MT-ND4L region rather than attempting to amplify the entire gene in one reaction.

  • Authentication protocols: Implement strict authentication procedures including negative controls, replicate amplifications, and when possible, verification across multiple sample types from the same individual.

These approaches maximize success rates when working with challenging field conditions and limited sample availability from endangered species.

What are the most promising future research directions for Varecia variegata MT-ND4L?

Future research on Varecia variegata MT-ND4L should focus on:

  • Comparative genomics: Expanding analysis across all Varecia subspecies to create a comprehensive map of MT-ND4L variation and its correlation with geographic distribution and ecological adaptations.

  • Functional genomics: Developing lemur-specific cellular models to assess the functional impact of MT-ND4L variants on mitochondrial function.

  • Conservation applications: Integrating MT-ND4L data with broader conservation genomics to inform reintroduction programs and manage captive breeding.

  • Biomedical relevance: Investigating how lemur MT-ND4L variants might inform our understanding of human mitochondrial disorders, particularly given the association between certain MT-ND4L variants and neurodegenerative conditions like Alzheimer's disease .

  • Technological innovations: Developing field-friendly techniques for rapid MT-ND4L genotyping to support conservation decisions in real-time.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.